China Traditional Chinese Medicine Holdings Co (570.HK) Stock Price

China Traditional Chinese Medicine Holdings Co Price

🇭🇰HKEX·CLOSED
1.58CNY
Market closed
Today +/-
Today %

China Traditional Chinese Medicine Holdings Co (570.HK) Stock | ISIN HK0000056256. The current China Traditional Chinese Medicine Holdings Co stock price is 1.58 CNY (2026). Revenue is 14.16 B CNY. Net income is 584.91 M CNY. The P/E ratio is 13.62. Market capitalization is 7.97 B CNY. China Traditional Chinese Medicine Holdings Co operates in the Health sector.

China Traditional Chinese Medicine Holdings Co stock price

Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of China Traditional Chinese Medicine Holdings Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how China Traditional Chinese Medicine Holdings Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing China Traditional Chinese Medicine Holdings Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

China Traditional Chinese Medicine Holdings Co Stock Price History
DateChina Traditional Chinese Medicine Holdings Co Price
Access this data via the Eulerpool API

China Traditional Chinese Medicine Holdings Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2005
868 M CNY
-128 M CNY
-803 M CNY
Jan 1, 2006
112 M CNY
29 M CNY
-346 M CNY
Jan 1, 2007
347 M CNY
32 M CNY
8 M CNY
Jan 1, 2008
396 M CNY
47 M CNY
18 M CNY
Jan 1, 2009
591 M CNY
83 M CNY
39 M CNY
Jan 1, 2010
818 M CNY
94 M CNY
53 M CNY
Jan 1, 2011
843 M CNY
83 M CNY
60 M CNY
Jan 1, 2012
1.03 B CNY
215 M CNY
168 M CNY
Jan 1, 2013
1.4 B CNY
255 M CNY
198 M CNY
Jan 1, 2014
2.65 B CNY
553.07 M CNY
413.09 M CNY
Jan 1, 2015
3.71 B CNY
648.12 M CNY
625.6 M CNY
Jan 1, 2016
6.53 B CNY
1.2 B CNY
966.93 M CNY
Jan 1, 2017
8.34 B CNY
1.76 B CNY
1.17 B CNY
Jan 1, 2018
11.26 B CNY
2.1 B CNY
1.44 B CNY
Jan 1, 2019
14.32 B CNY
2.43 B CNY
1.59 B CNY

China Traditional Chinese Medicine Holdings Co Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jun 10, 2026, 1:59 PM
 
REVENUE (M CNY)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M CNY)
NET INCOME (M CNY)
NET INCOME GROWTH (%)
DIV. (CNY)
DIV. GROWTH (%)
SHARES (M)
DOCUMENTS
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales China Traditional Chinese Medicine Holdings Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue China Traditional Chinese Medicine Holdings Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare China Traditional Chinese Medicine Holdings Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares China Traditional Chinese Medicine Holdings Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against China Traditional Chinese Medicine Holdings Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

China Traditional Chinese Medicine Holdings Co stock margins

The China Traditional Chinese Medicine Holdings Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of China Traditional Chinese Medicine Holdings Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for China Traditional Chinese Medicine Holdings Co.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2005
-12.33 %
-14.75 %
-92.51 %
Jan 1, 2006
39.29 %
25.89 %
-308.93 %
Jan 1, 2007
34.87 %
9.22 %
2.31 %
Jan 1, 2008
35.61 %
11.87 %
4.55 %
Jan 1, 2009
48.05 %
14.04 %
6.6 %
Jan 1, 2010
55.75 %
11.49 %
6.48 %
Jan 1, 2011
53.97 %
9.85 %
7.12 %
Jan 1, 2012
54.7 %
20.85 %
16.29 %
Jan 1, 2013
59.21 %
18.28 %
14.19 %
Jan 1, 2014
62 %
20.87 %
15.59 %
Jan 1, 2015
59.33 %
17.47 %
16.87 %
Jan 1, 2016
57.98 %
18.42 %
14.8 %
Jan 1, 2017
55.79 %
21.06 %
14.04 %
Jan 1, 2018
55.01 %
18.65 %
12.78 %
Jan 1, 2019
59.88 %
16.98 %
11.09 %

China Traditional Chinese Medicine Holdings Co Stock Revenue, EBIT, Earnings per Share

The China Traditional Chinese Medicine Holdings Co earnings per share therefore indicates how much revenue China Traditional Chinese Medicine Holdings Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2005
1.05 CNY
-0.15 CNY
-0.97 CNY
Jan 1, 2006
0.13 CNY
0.03 CNY
-0.42 CNY
Jan 1, 2007
0.42 CNY
0.04 CNY
0.01 CNY
Jan 1, 2008
0.48 CNY
0.06 CNY
0.02 CNY
Jan 1, 2009
0.38 CNY
0.05 CNY
0.02 CNY
Jan 1, 2010
0.47 CNY
0.05 CNY
0.03 CNY
Jan 1, 2011
0.47 CNY
0.05 CNY
0.03 CNY
Jan 1, 2012
0.58 CNY
0.12 CNY
0.09 CNY
Jan 1, 2013
0.68 CNY
0.12 CNY
0.1 CNY
Jan 1, 2014
1.05 CNY
0.22 CNY
0.16 CNY
Jan 1, 2015
1.01 CNY
0.18 CNY
0.17 CNY
Jan 1, 2016
1.47 CNY
0.27 CNY
0.22 CNY
Jan 1, 2017
1.88 CNY
0.4 CNY
0.26 CNY
Jan 1, 2018
2.33 CNY
0.44 CNY
0.3 CNY
Jan 1, 2019
2.84 CNY
0.48 CNY
0.32 CNY

China Traditional Chinese Medicine Holdings Co business model & stock analysis

China Traditional Chinese Medicine Holdings Co., Ltd. operates as an investment holding company, which engages in the research and development, production and sale of Chinese medicine and pharmaceutical products. The company employs 17,373 full-time employees The firm operates through 12 subsidiaries, including Sinopharm Group Dezhong (Foshan) Pharmaceutical Co., Ltd., Sinopharm Group Feng Liao Xing (Foshan) Pharmaceutical Co., Ltd., Sinopharm Group Guangdong Medi-World Pharmaceutical Co., Ltd., Sinopharm Group Luya (Shandong) Pharmaceutical Co., Ltd., Sinopharm Group Feng Liao Xing (Foshan) Medicinal Material & Slices Co., Ltd., Foshan Winteam Pharmaceutical Sales Company Limited, Sinopharm Group Tongjitang (Guizhou) Pharmaceutical Co., Ltd., Sinopharm Group Jingfang (Anhui) Pharmaceutical Co., Ltd., Sinopharm Group Longlife (Guizhou) Pharmaceutical Co., Ltd., Qinghai Pulante Pharmaceutical Co., Ltd., Guizhou Zhongtai Biological Technology Company Limited and its subsidiaries and Jiangyin Tianjiang Pharmaceutical Co., Ltd. and its subsidiaries.

China Traditional Chinese Medicine Holdings Co Eulerpool Fair Value

China Traditional Chinese Medicine Holdings Co historical P/E ratio, EBIT multiple, and P/S ratio

China Traditional Chinese Medicine Holdings Co annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

China Traditional Chinese Medicine Holdings Co shares outstanding

The number of shares was China Traditional Chinese Medicine Holdings Co in 2025 — This indicates how many shares 5.036 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2005
830 M base_Shares
Jan 1, 2006
830 M base_Shares
Jan 1, 2007
831 M base_Shares
Jan 1, 2008
831 M base_Shares
Jan 1, 2009
1.56 B base_Shares
Jan 1, 2010
1.73 B base_Shares
Jan 1, 2011
1.78 B base_Shares
Jan 1, 2012
1.78 B base_Shares
Jan 1, 2013
2.05 B base_Shares
Jan 1, 2014
2.53 B base_Shares
Jan 1, 2015
3.69 B base_Shares
Jan 1, 2016
4.45 B base_Shares
Jan 1, 2017
4.43 B base_Shares
Jan 1, 2018
4.82 B base_Shares
Jan 1, 2019
5.04 B base_Shares

China Traditional Chinese Medicine Holdings Co Dividend History

23 years of dividend payments

YearAnnual DividendYoY ChangePayments
20250.01CNY 86.5%
Jun 23, 20250CNY 93.2%1/2
Jul 3, 20250CNY 0.0%2/2
20230.05CNY 29.6%
20220.07CNY 10.5%
20210.07CNY 39.9%
20200.05CNY 57.6%
20190.11CNY 2.1%
20180.11CNY 31.9%
20170.08CNY 29.5%
20160.06CNY 14.1%
20120.08CNY 971.4%

China Traditional Chinese Medicine Holdings Co dividend history and estimates

In 2025, China Traditional Chinese Medicine Holdings Co paid a dividend amounting to 0.01 CNY. Dividend means that China Traditional Chinese Medicine Holdings Co distributes a portion of its profits to its owners.
  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Invalid Date
0.01 CNY
0.01 CNY
Invalid Date
0.01 CNY
0.01 CNY
Jan 1, 2012
0.08 CNY
0 CNY
Invalid Date
0.06 CNY
0.06 CNY
Jan 1, 2017
0.08 CNY
0 CNY
Jan 1, 2018
0.11 CNY
0 CNY
Jan 1, 2019
0.11 CNY
0 CNY
Invalid Date
0.05 CNY
0.05 CNY
Invalid Date
0.07 CNY
0.07 CNY
Invalid Date
0.07 CNY
0.07 CNY
Invalid Date
0.05 CNY
0.05 CNY
Jan 1, 2025
0.01 CNY
0 CNY
Invalid Date
0 CNY
0.04 CNY
Invalid Date
0 CNY
0.05 CNY

China Traditional Chinese Medicine Holdings Co dividend payout ratio

In 2025, China Traditional Chinese Medicine Holdings Co had a payout ratio of 35.37%. The payout ratio indicates the percentage of the company's profits that China Traditional Chinese Medicine Holdings Co distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2005
26.75 %
Jan 1, 2006
26.75 %
Jan 1, 2007
26.75 %
Jan 1, 2008
25 %
Jan 1, 2009
35 %
Jan 1, 2010
26.75 %
Jan 1, 2011
26.75 %
Jan 1, 2012
83.33 %
Jan 1, 2013
26.75 %
Jan 1, 2014
26.75 %
Jan 1, 2015
26.75 %
Jan 1, 2016
29.64 %
Jan 1, 2017
31.58 %
Jan 1, 2018
36.86 %
Jan 1, 2019
35.61 %
Price targets and forecasts for China Traditional Chinese Medicine Holdings Co are not yet available.

EESG©

Eulerpool ESG Scorecard© for the China Traditional Chinese Medicine Holdings Co stock

66/100
96
Environment
81
Social
21
Governance
E

Environment

20
Scope 1 - Direct Emissions104,425.2
Scope 2 - Indirect emissions from purchased energy133,194
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions237,619.2
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees49.376
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

China Traditional Chinese Medicine Holdings Co shareholder structure

% Name
33.46152%
China National Pharmaceutical Group Corporation
China National Pharmaceutical Group Corporation
12%
Ping An Life Insurance Company of China, Ltd
Ping An Life Insurance Company of China, Ltd
5.03619%
Millennium Management LLC
Millennium Management LLC
1.92428%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
1.38862%
Bosera Asset Management Co., Ltd.
Bosera Asset Management Co., Ltd.
1.16327%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.
0.95516%
Athos Capital Limited
Athos Capital Limited
0.68438%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
0.30827%
American Century Investment Management, Inc.
American Century Investment Management, Inc.
0.20946%
E Fund Management Co. Ltd.
E Fund Management Co. Ltd.
...

China Traditional Chinese Medicine Holdings Co Executives and Management Board

WY

Mr. Wenming Yang

(60)

Non-Executive Director · since 2018

Compensation2.6 M CNY
XC

Mr. Xueren Cheng

(61)

Non-Executive Director · since 2018

Compensation2.49 M CNY
DZ

Mr. Dongji Zhao

(56)

Chief Compliance Officer, Vice President, Joint Company Secretary, Chief Legal Advisor · since 2013

Compensation1.53 M CNY
WL

Mr. Weidong Li

(56)

Non-Executive Independent Director

Compensation279,000 CNY
LQ

Mr. Ling Qin

(65)

Non-Executive Independent Director

Compensation279,000 CNY

Frequently asked questions about China Traditional Chinese Medicine Holdings Co

All fundamentals and in-depth analysis of China Traditional Chinese Medicine Holdings Co

Our stock analysis for China Traditional Chinese Medicine Holdings Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China Traditional Chinese Medicine Holdings Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.